Strategies for Flow Cytometric Profiling of BCR Immunoglobulin Heavy Chain Isotypes: A Comparative Assessment of Fc Receptor Blocking Agents
Description
This study aims to assess the impact of FcR blocking reagents on detection of BCR IgH isotypes IgM, IgD, IgA1-2, and IgG1-4.
Blood samples were collected from healthy volunteers in lithium heparin tubes, followed by the isolation of PBMCs utilizing BioColl density gradient centrifugation. The blood samples were diluted at a ratio of 1:1 in PBS with a pH of 7.4 and then centrifuged at 800 g for 20 minutes at RT. The PBMC interphases were harvested and washed three times with PBS containing 2 mM EDTA. Subsequently, PBMCs were resuspended in cRPMI medium. PBMCs were treated with five different FcR blocking reagents prior to staining. For each donor, PBMCs were divided into two groups, with each group containing five samples. One group was stained directly with an immunophenotyping panel without being washed following the application of FCR blocking reagent. The other group was applied washing before staining.
Ultimately, the samples were incubated with an 8-color immunophenotyping panel targeting B-cell markers:
|
Target |
Fluorochrome |
Producer |
Clone |
Isotype |
Dilution |
|
CD19 |
APC-eFluor780 |
eBioscience |
HIB19 |
Mouse, IgG1, kappa |
1:100 |
|
IgM |
PerCP/Cy5.5 |
Biolegend |
MHM-88 |
Mouse, IgG1, kappa |
1:100 |
|
IgD |
AF700 |
Biolegend |
IA6-2 |
Mouse IgG2a, kappa |
1:100 |
|
IgA |
VioBlue |
Miltenyi |
IS11-8E10 |
Mouse, IgG1, kappa |
1:200 |
|
IgA2 |
PE |
Miltenyi |
IS11-21E11 |
Mouse, IgG1, kappa |
1:100 |
|
IgG1 |
AF488 |
AF488/Lumiprobe |
MH161-1 |
Mouse, IgG2b, kappa |
1:600 |
|
IgG1 |
Dylight550 |
Dylight/Innova Bio |
MH161-1 |
Mouse, IgG2b, kappa |
1:500 |
|
IgG2 |
Dylight550 |
Dylight/Innova Bio |
HP6002 |
Mouse, IgG1, kappa |
1:100 |
|
IgG3 |
AF488 |
AF488/Lumiprobe |
MH163-1 (HP6095) |
Mouse, IgG2b, kappa |
1:400 |
|
IgG4 |
APC |
Cytognos |
SAG4 |
Mouse, IgG1, kappa |
1:400 |
|
CD3 |
BV605 |
Biolegend |
OKT3 |
Mouse IgG2a, kappa |
1:200 |
|
CD14 |
BV605 |
Biolegend |
63D3 |
Mouse, IgG1, kappa |
1:200 |
|
CD16 |
BV605 |
Biolegend |
3G8 |
Mouse, IgG1, kappa |
1:200 |
|
Viability dye |
Zombie yellow |
Biolegend |
|
|
1:100 |
Cells were analyzed on a FACS Aria IIIu (Becton, Dickinson and Company, Franklin Lakes, NJ). B cells were gated as live ZombieYellow-CD3-CD14-CD16-CD19+ lymphocyte. IgM and IgD expression was used to differentiate class-switched (IgM-IgD-) and non-switched (IgM+IgD+) B cells. Next, the IgA+ population, gated from switched B cells, was segregated into IgA1+ (gated as IgA+IgA2-) and IgA2+ (IgA+IgA2+) B cells. The IgA- population was segregated into IgG1+, IgG2+, IgG3+ and IgG4+ B cells. Gates were set based on fluorescence minus one (FMO) controls.
To evaluate the effectiveness of the different blocking reagents used in our study on preventing non-specific binding of mouse monoclonal antibodies (mAbs), PBMCs were incubated with isotype control antibodies. Mouse IgG1, IgG2a, and IgG2b antibodies, all conjugated with PE, were evaluated for their non-specific binding to CD14+ monocytes. Prior to staining, the cells were divided into two groups and were treated with FcR blocking reagent as mentioned above. The details concerning the reagents are below:
|
Target |
Fluorochrome |
Brand |
Clone |
Isotype |
Dilution |
|
IgG1 |
PE |
Biolegend |
MOPC-21 |
Mouse, IgG1, kappa |
1:100 |
|
IgG2a |
PE |
Biolegend |
MOPC-173 |
Mouse IgG2a, kappa |
1:100 |
|
IgGb |
PE |
Biolegend |
MPC-11 |
Mouse, IgG2b, kappa |
1:100 |
|
CD14 |
BV605 |
Biolegend |
63D3 |
Mouse, IgG1, kappa |
1:200 |
|
Viability dye |
Zombie green |
Biolegend |
|
|
1:100 |
The analysis of all flow cytometry data was performed using FlowJo v10 software (BD Biosciences). Statistical analysis was conducted using GraphPad Prism 9 software (GraphPad, La Jolla, USA).
Files
Additional details
Dates
- Submitted
-
2024-08-15